Hemithoracic Arc Radiotherapy Post Pleural Decortication
Recruiting · NCT06910449 · Interventional (participants receive a specific treatment) · Lead sponsor: Cairo University
View the official record on ClinicalTrials.gov →Interventions studied
hemithoracic Volumetric Arc Radiotherapy post Pleural decortication
What this trial is about
Malignant Pleural Mesothelioma is an aggressive and refractory disease , the most aggressive treatment plan offered to these patients include trimodalitiy approach with chemotherapy as the mainstay of treatment . the rationale of post operative Radiotherapy is to sterilize the post operative volume to reduce local failure meanwhile minimizing toxicities in this trial we are going to assess the safety and efficacy of Radiotherapy in Mesothelioma patients poat Pleural decortication
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Evidence of metastatic disease.
- Underwent Pleural decortication.
- Able to provide informed consent.
Exclusion criteria
- Poor pulmonary function tests.
- Recurrent or palliative cases.
- Inability to attend full course of Radiotherapy or follow up visits.
Where it is running
1 location listed.
- national Cancer Institute Cairo university - Cairo, Fom Elkhalig, Egypt